Albumin in sepsis;Albumine dans les états infectieux graves

Annales Francaises d'Anesthesie et de Reanimation

Volumn 29, Issue 9, 2010, Pages 629-634

  Tamion, F ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Human serum albumin; Hypoalbuminemia; Intensive care; Oxidative stress

Indexed keywords

ALBUMIN; HUMAN SERUM ALBUMIN;

COLLAPSE; CRITICALLY ILL PATIENT; CRYSTALLOID; HUMAN; HYPOALBUMINEMIA; INTENSIVE CARE UNIT; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; PROTEIN TERTIARY STRUCTURE; SEPSIS; SHORT SURVEY;

HUMANS; SEPSIS; SERUM ALBUMIN;

EID: 77956184859     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.05.035     Document Type: Short Survey

References (51)

1. Roche M., Rondeau P., Singh N.R., Tarnus E., Bourdon E. The antioxidant properties of serum albumin. FEBS Lett 2008, 582:1783-1787.
2. Quinlan G.J., Martin G.S., Evans T.W. Albumin: biochemical properties and therapeutic potential. Hepatology 2005, 41:1211-1219.
3. Fasano M., Curry S., Terreno E., et al. The extraordinary ligand binding properties of human serum albumin. IUBMB Life 2005, 57:787-796.
4. Oettl K., Stauber R.E. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 2007, 151:580-590.
5. Bourdon E., Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal 2001, 3:293-311.
6. Moshage H.J., Janssen J.A., Franssen J.H., Hafkenscheid J.C., Yap S.H. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest 1987, 79:1635-1641.
7. Horowitz I.N., Tai K. Hypoalbuminemia in critically ill children. Arch Pediatr Adolesc Med 2007, 161:1048-1052.
8. Wang X., Tanus-Santos J.E., Reiter C.D., et al. Biological activity of nitric oxide in the plasmatic compartment. Proc Natl Acad Sci U S A 2004, 101:11477-11482.
9. Carballal S., Radi R., Kirk M.C., et al. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 2003, 42:9906-9914.
10. Kim S.B., Yang W.S., Min W.K., Lee S.K., Park J.S. Reduced oxidative stress in hypoalbuminemic CAPD patients. Perit Dial Int 2000, 20:290-294.
11. Quinlan G.J., Margarson M.P., Mumby S., Evans T.W., Gutteridge J.M. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond) 1998, 95:459-465.
12. Quinlan G.J., Mumby S., Martin G.S., et al. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004, 32:755-759.
13. Wu Y.W., Tsai Y.H. Characterization of and mechanism for copper-induced thioureation of serum albumin. Bioconjug Chem 2008, 19:1822-1830.
14. Roberts A., Bar-Or D., Winkler J.V., Rael L.T. Copper-induced oxidation of epinephrine: protective effect of D-DAHK, a synthetic analogue of the high affinity copper binding site of human albumin. Biochem Biophys Res Commun 2003, 304:755-757.
15. Poole L.B., Karplus P.A., Claiborne A. Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 2004, 44:325-347.
16. Powers K.A., Kapus A., Khadaroo R.G., et al. Twenty-five percent albumin prevents lung injury following shock/resuscitation. Crit Care Med 2003, 31:2355-2363.
17. Alam H.B., Stanton K., Koustova E., et al. Effect of different resuscitation strategies on neutrophil activation in a swine model of hemorrhagic shock. Resuscitation 2004, 60:91-99.
18. Cantin A.M., Paquette B., Richter M., Larivee P. Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. Am J Respir Crit Care Med 2000, 162:1539-1546.
19. Bar-Or D., Bar-Or R., Rael L.T., et al. Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 2005, 33:1638-1641.
20. Gryzunov Y.A., Arroyo A., Vigne J.L., et al. Binding of fatty acids facilitates oxidation of cysteine-34 and converts copper-albumin complexes from antioxidants to prooxidants. Arch Biochem Biophys 2003, 413:53-66.
21. Soejima A., Matsuzawa N., Miyake N., et al. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients. Clin Nephrol 1999, 51:92-97.
22. Humpert P.M., Lukic I.K., Thorpe S.R., et al. AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis. J Leukoc Biol 2009, 86:589-597.
23. Bopp C., Bierhaus A., Hofer S., et al. Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit Care 2008, 12:201.
24. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998;317:235-40.
25. Finfer S., Bellomo R., Boyce N., et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256.
26. Wilkes M.M., Navickis R.J. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001, 135:149-164.
27. Boldt J., Brosch C., Ducke M., Papsdorf M., Lehmann A. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 2007, 35:2740-2746.
28. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60.
29. Meziani F., Kremer H., Tesse A., et al. Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses. Am J Pathol 2007, 171:1753-1761.
30. Rehm M., Zahler S., Lotsch M., et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004, 100:1211-1223.
31. Jacob M., Bruegger D., Rehm M., et al. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006, 104:1223-1231.
32. Jacob M., Bruegger D., Rehm M., et al. The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 2007, 73:575-586.
33. Jacob M., Rehm M., Loetsch M., et al. The endothelial glycocalyx prefers albumin for evoking shear stress-induced, nitric oxide-mediated coronary dilatation. J Vasc Res 2007, 44:435-443.
34. Jacob M., Chappell D., Conzen P., et al. Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials. Crit Care 2008, 12:R34.
35. Uriz J., Gines P., Cardenas A., et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 2000, 33:43-48.
36. Schortgen F., Girou E., Deye N., Brochard L. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008, 34:2157-2168.
37. Ballmer P.E. Causes and mechanisms of hypoalbuminaemia. Clin Nutr 2001, 20:271-273.
38. Holland P.C., Hancock S.W., Hodge D., et al. Degradation of albumin in meningococcal sepsis. Lancet 2001, 357:2102-2104.
39. Musante L., Bruschi M., Candiano G., et al. Characterization of oxidation end product of plasma albumin 'in vivo'. Biochem Biophys Res Commun 2006, 349:668-673.
40. Faure P., Wiernsperger N., Polge C., Favier A., Halimi S. Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. Clin Sci (Lond) 2008, 114:251-256.
41. Sakata N., Moh A., Takebayashi S. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin. Heart Vessels 2002, 17:22-29.
42. Tincani E., Mazzali F., Morini L. Hypoalbuminemia as a risk factor for over-anticoagulation. Am J Med 2002, 112:247-248.
43. Cho Y.M., Choi I.S., Bian R.X., et al. Serum albumin at admission for prediction of functional outcome in ischaemic stroke patients. Neurol Sci 2008, 29:445-449.
44. Yuan X.Y., Zhang C.H., He Y.L., et al. Is albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery? A prospective randomized controlled trial. Am J Surg 2008, 196:751-755.
45. Mangialardi R.J., Martin G.S., Bernard G.R., et al. Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med 2000, 28:3137-3145.
46. Vincent J.L., Dubois M.J., Navickis R.J., Wilkes M.M. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003, 237:319-334.
47. Vincent J.L., Navickis R.J., Wilkes M.M. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 2004, 32:2029-2038.
48. Tokunaga C., Bateman R.M., Boyd J., et al. Albumin resuscitation improves ventricular contractility and myocardial tissue oxygenation in rat endotoxemia. Crit Care Med 2007, 35:1341-1347.
49. Moran L.K., Gutteridge J.M., Quinlan G.J. Thiols in cellular redox signalling and control. Curr Med Chem 2001, 8:763-772.
50. Dubois M.J., Orellana-Jimenez C., Melot C., et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 2006, 34:2536-2540.
51. Martin G.S., Moss M., Wheeler A.P., et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005, 33:1681-1687.